首页> 外文期刊>Transplant infectious disease: an official journal of the Transplantation Society >Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia
【24h】

Use of a novel virus detection assay to identify coronavirus HKU1 in the lungs of a hematopoietic stem cell transplant recipient with fatal pneumonia

机译:使用新型病毒检测方法鉴定患有致命性肺炎的造血干细胞移植受者肺部冠状病毒HKU1

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A 38-year-old female patient with systemic lupus erythematosus presented with pulmonary infiltrates and hypoxemia for several months following immunodepleting autologous hematopoietic stem cell transplantation. She was treated for influenza, which was isolated repeatedly from oropharynx and bronchoalveolar lavage (BAL) fluids, and later empirically for lupus pneumonitis, but died 6 months after transplant. Autopsy findings failed to show influenza in the lungs or lupus pneumonitis. A novel generic polymerase chain reaction (PCR)-based assay using degenerate primers identified human coronavirus (CoV) HKU1 RNA in BAL fluid at autopsy. CoV was confirmed by virus-specific PCRs of lung tissue at autopsy. Electron microscopy showed viral particles consistent with CoV HKU1 in lung tissue both at autopsy and from a previous biopsy. Although human CoV HKU1 infection is not usually severe, in highly immunocompromised patients, it can be associated with fatal pneumonia.
机译:一名38岁女性系统性红斑狼疮患者在免疫耗竭自体造血干细胞移植后几个月出现肺浸润和低氧血症。她接受过流感治疗,从口咽和支气管肺泡灌洗液(BAL)中反复分离出来,后来凭经验治疗狼疮性肺炎,但在移植后6个月死亡。尸检结果未能显示出肺部或狼疮性肺炎的流行性感冒。基于简并引物的新型基于通用聚合酶链反应(PCR)的检测方法在尸检时可识别BAL液中的人类冠状病毒(CoV)HKU1 RNA。尸检时通过肺组织的病毒特异性PCR确认了CoV。电子显微镜检查显示,在尸体解剖和先前的活检中,肺组织中的病毒颗粒与CoV HKU1一致。尽管人类冠状病毒HKU1感染通常并不严重,但在高度免疫受损的患者中,它可能与致命性肺炎有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号